VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 229 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $125,927,453 | -6.9% | 5,133,610 | -11.7% | 0.73% | -9.2% |
Q1 2023 | $135,314,398 | -6.4% | 5,814,972 | +1.8% | 0.80% | -5.0% |
Q4 2022 | $144,533,008 | +24.2% | 5,710,510 | -5.4% | 0.84% | +21.2% |
Q3 2022 | $116,389,909 | -18.4% | 6,036,821 | +7.8% | 0.70% | -10.9% |
Q2 2022 | $142,697,025 | -1.0% | 5,602,553 | 0.0% | 0.78% | +28.8% |
Q1 2022 | $144,097,663 | -37.8% | 5,602,553 | +1.2% | 0.61% | -27.5% |
Q4 2021 | $231,846,000 | -7.5% | 5,537,291 | -3.9% | 0.84% | -4.6% |
Q3 2021 | $250,721,000 | -5.5% | 5,761,045 | +2.7% | 0.88% | -1.2% |
Q2 2021 | $265,329,000 | -6.2% | 5,611,875 | +1.7% | 0.89% | -19.9% |
Q1 2021 | $282,941,000 | +92.1% | 5,518,644 | +0.3% | 1.11% | +75.2% |
Q4 2020 | $147,290,000 | -22.0% | 5,499,999 | 0.0% | 0.63% | -34.0% |
Q3 2020 | $188,815,000 | -16.2% | 5,499,999 | 0.0% | 0.96% | -28.7% |
Q2 2020 | $225,335,000 | +19.6% | 5,499,999 | 0.0% | 1.34% | -3.2% |
Q1 2020 | $188,485,000 | +172.5% | 5,499,999 | 0.0% | 1.39% | +207.3% |
Q4 2019 | $69,162,000 | – | 5,499,999 | – | 0.45% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |